ELISA and Cell-Based Assays Confirm the Low Immunogenicity of VNAR Therapeutic Constructs in a Mouse Model of Human RA: An Encouraging Milestone to Further Clinical Drug Development.

Autor: Ubah, Obinna C.1 (AUTHOR), Porter, Andrew J.1,2 (AUTHOR), Barelle, Caroline J.1 (AUTHOR)
Zdroj: Journal of Immunology Research. 2/3/2020, p1-14. 14p. 8 Graphs.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje